$524.58
0.04% yesterday
NYSE, Oct 13, 10:04 pm CET

Thermo Fisher Scientific Stock price

$524.58
+50.12 10.56% 1M
+75.25 16.75% 6M
+4.35 0.84% YTD
-79.21 13.12% 1Y
+14.04 2.75% 3Y
+57.05 12.20% 5Y
+399.10 318.06% 10Y
+494.48 1,642.79% 20Y
NYSE, Closing price Mon, Oct 13 2025
-0.22 0.04%

Key metrics

Basic
Market capitalization
$198.1b
Enterprise Value
$226.9b
Net debt
$28.8b
Cash
$6.4b
Shares outstanding
377.5m
Valuation (TTM | estimate)
P/E
30.1 | 23.1
P/S
4.6 | 4.5
EV/Sales
5.3 | 5.1
EV/FCF
36.8
P/B
3.9
Dividends
DPS
$1.56
Yield 1Y | 5Y
0.3% | 0.2%
Growth 1Y | 5Y
11.4% | 15.5%
Payout 1Y | 3Y
9.4% | 8.4%
Increased
7 Years
Financials (TTM | estimate)
Revenue
$43.2b | $44.4b
EBITDA
$8.3b | $11.1b
EBIT
$7.9b | $10.0b
Net Income
$6.6b | $8.6b
Free Cash Flow
$6.2b
Growth (TTM | estimate)
Revenue
2.1% | 3.5%
EBITDA
-23.2% | 14.7%
EBIT
5.2% | 29.6%
Net Income
5.8% | 35.5%
Free Cash Flow
-22.5%
Margin (TTM | estimate)
Gross
41.3%
EBITDA
19.2% | 25.0%
EBIT
18.2%
Net
15.2% | 19.4%
Free Cash Flow
14.3%
Financial Health
Equity Ratio
50.9%
Return on Equity
12.8%
ROCE
8.9%
ROIC
-
Debt/Equity
0.7
More
EPS
$17.4
FCF per Share
$16.3
Short interest
1.1%
Employees
125k
Rev per Employee
$340.0k
Show more

Is Thermo Fisher Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

Thermo Fisher Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Thermo Fisher Scientific forecast:

27x Buy
79%
7x Hold
21%

Analyst Opinions

34 Analysts have issued a Thermo Fisher Scientific forecast:

Buy
79%
Hold
21%

Financial data from Thermo Fisher Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
43,212 43,212
2% 2%
100%
- Direct Costs 25,350 25,350
1% 1%
59%
17,862 17,862
3% 3%
41%
- Selling and Administrative Expenses 8,085 8,085
4% 4%
19%
- Research and Development Expense 1,414 1,414
7% 7%
3%
8,286 8,286
23% 23%
19%
- Depreciation and Amortization 429 429
87% 87%
1%
EBIT (Operating Income) EBIT 7,857 7,857
5% 5%
18%
Net Profit 6,584 6,584
6% 6%
15%

In millions USD.

Don't miss a Thing! We will send you all news about Thermo Fisher Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Thermo Fisher Scientific Stock News

Positive
The Motley Fool
about 21 hours ago
Franklin Street Advisors reported purchasing 87,872 shares of Thermo Fisher Scientific in the quarter ended September 30, 2025. This was an estimated $40.90 million trade based on the average price for the quarter, per its October 9, 2025, SEC filing.
Neutral
The Motley Fool
2 days ago
On October 10, 2025, wealth management company Douglas Lane & Associates disclosed a purchase of Thermo Fisher Scientific valued at approximately $7.79 million, based on the average price for Q3 2025.
Neutral
Business Wire
6 days ago
WEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced a new laboratory developed test for post-transplant biopsy assessment designed to improve the detection of lung transplant rejection and injury, delivering quantifiable results that may increase diagnostic confidence and guide timely treatment. Due to the significant risk of reject...
More Thermo Fisher Scientific News

Company Profile

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Head office United States
CEO Marc Casper
Employees 125,000
Founded 1960
Website www.thermofisher.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today